Most Recent
Lawyers representing two class actions against the state of Queensland over alleged unlawful removals of Indigenous children have called on the state to produce unredacted files about the lead applicants.
Macquarie Capital has hit back at a class action over an alleged misleading prospectus for Nuix’s $1.8 billion IPO, saying it was entitled as underwriter to rely on the software company's promises.
3M is now facing two class actions in Victoria, after being hit with a case on behalf of ADF members who claim they suffered hearing loss from using defective combat earplugs.
Legal fees will eat up more than half of a $3.5 million settlement reached in a class action over deaths at a NSW aged care facility during the COVID-19 pandemic.
Healthcare giant Johnson & Johnson is facing a new class action alleging it sold talcum powder that was contaminated with asbestos and caused reproductive system cancers in women.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
Funder LLS has urged the court to approve its 20 per cent cut of a $202 million settlement in a stolen wages class action, saying that reducing the "bottom end" rate could deter investments in public interest class actions.
The Commonwealth says funder LLS should not be allowed a 20 per cent cut of a stolen wages class action settlement of up to $202 million, arguing it could produce an “excessive deduction”.